| Literature DB >> 33179747 |
Shu Tadaka1, Eiji Hishinuma1,2, Shohei Komaki3, Ikuko N Motoike1,4, Junko Kawashima1, Daisuke Saigusa1,5, Jin Inoue1, Jun Takayama1,2, Yasunobu Okamura1,2, Yuichi Aoki1,4, Matsuyuki Shirota1,2,5,4, Akihito Otsuki1,5, Fumiki Katsuoka1,5, Atsushi Shimizu3,6, Gen Tamiya1,5, Seizo Koshiba1,2, Makoto Sasaki3,6, Masayuki Yamamoto1,2,5, Kengo Kinoshita1,2,4.
Abstract
In the Tohoku Medical Megabank project, genome and omics analyses of participants in two cohort studies were performed. A part of the data is available at the Japanese Multi Omics Reference Panel (jMorp; https://jmorp.megabank.tohoku.ac.jp) as a web-based database, as reported in our previous manuscript published in Nucleic Acid Research in 2018. At that time, jMorp mainly consisted of metabolome data; however, now genome, methylome, and transcriptome data have been integrated in addition to the enhancement of the number of samples for the metabolome data. For genomic data, jMorp provides a Japanese reference sequence obtained using de novo assembly of sequences from three Japanese individuals and allele frequencies obtained using whole-genome sequencing of 8,380 Japanese individuals. In addition, the omics data include methylome and transcriptome data from ∼300 samples and distribution of concentrations of more than 755 metabolites obtained using high-throughput nuclear magnetic resonance and high-sensitivity mass spectrometry. In summary, jMorp now provides four different kinds of omics data (genome, methylome, transcriptome, and metabolome), with a user-friendly web interface. This will be a useful scientific data resource on the general population for the discovery of disease biomarkers and personalized disease prevention and early diagnosis.Entities:
Year: 2020 PMID: 33179747 DOI: 10.1093/nar/gkaa1034
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971